EPA Proposes TSCA Inventory Reporting Modifications

In the Federal Register issue of 08/13/2010, the Environmental Protection Agency (EPA) released for public comment a proposed rule that would, if adopted, significantly change the TSCA Inventory Update Reporting (IUR).

The first part of the notice, "Supplementary Information", explains the proposed changes to 40 CFR Parts 704, 710, and 711. The text of the proposed rule follows the Supplementary Information.

In the Supplementary Information, EPA states that it is proposing modifications to the IUR

 to meet four primary goals:
    1. To tailor the information collected to better meet the Agency's
overall information needs.
    2. To increase its ability to effectively provide public access to
the information.
    3. To obtain new and updated information relating to potential
exposures to a subset of chemical substances listed on the TSCA
Inventory.
    4. To improve the usefulness of the information reported.
EPA believes that expanding the range of chemical substances for which
comprehensive information is to be reported and adjusting the specific
reported information, the method and

[[Page 49659]]

frequency of collecting the information, and CBI requirements will
accomplish these goals.

Reading the Supplemental Information reveals a fifth, unstated goal - the creation of uniform reporting standards that will provide EPA with the information it needs to "identify and take follow-up action on chemical substances that may pose potential risks to human health or the environment" in a more efficent and timely manner, cutting the amount of time EPA staff will need to spend reviewing submitted information, determining if EPA action is required and uploading the information to a publicly available databse.

Under the proposed rule, EPA would require information to be submitted via agency supplied web based application

EPA believes the proposed requirement to use e-IURweb to report
electronically would eliminate problems related to the scanning of
paper documents, incorrect chemical identities, and other errors
introduced by the submitter. These errors substantially delayed the
availability of the IUR information to both internal EPA programs, such
as the Existing Chemicals Program, and the public. . . . EPA believes the
required use of e-IURweb and CDX would reduce the reporting burden on
industry by reducing both the cost and the time required to review,
edit, and transmit data to the Agency.

The terms manufacture, manufacturer, and site  would be redefined:

with this proposal . . . manufacture would be defined . . . to mean "to manufacture, produce, or import for commercial purpose.

Also with this proposal, manufacturer would be defined . . . to mean "a person who manufactures a chemical substance. "

The term site

would be defined under the IUR
rule to mean ``a contiguous property unit. Property divided only by a
public right-of-way shall be considered one site. More than one plant
may be located on a single site.
    (a) For chemical substances manufactured under contract, i.e., by a
toll manufacturer, the site is the location where the chemical
substance is physically manufactured.
    (b) The site for an importer who imports a chemical substance
described in 40 CFR 711.5 is the U.S. site of the operating unit within
the person's organization that is directly responsible for importing
the chemical substance. The import site, in some cases, may be the
organization's headquarters in the United States. If there is no such
operating unit or headquarters in the United States, the site address
for the importer is the U.S. address of an agent acting on behalf of
the importer who is authorized to accept service of process for the
importer.
    (c) For portable manufacturing units sent out to different
locations from a single distribution center, the distribution center
shall be considered the site.''
 

The proposed rule would also modify the definitions of the terms "commercial use", consumer use" "reporting year" "submission period" and add a definition for the term "industrial function".

The method of determining if a manufacturer or importer is subject to IUR reporting would be changed:

EPA is proposing to modify the method used to determine whether a
person is subject to IUR reporting. The proposed method would be to
determine whether, for any calendar year since the last principal
reporting year, a chemical substance was manufactured (including
imported) at a site in production volumes of 25,000 lb. or greater. The
proposed method would be effective after the 2011 IUR submission
period.
 

EPA is proposing this change because of the mounting evidence that
many chemical substances, even larger volume chemical substances, often
experience wide fluctuations in manufacturing volume from year to year.
 

Chemical substances coverd by IUR reporting would be changed to exempt water, both naturally occuring and manufactured, fully exempt the polymers starch, dextrin, and maltodextrin, and making chemical substances subject to enforceable consent decrees ineligible for exemption.

Data to be reported would change as well. The company name to be reported would be the name of the parent company, including its Dunns & Bradstreet (DNB) number, the chemical name(s) supplied would be the name as listed on the TSCA Inventory, production volume of chemicals manufactured, exported and/or imported would be reported on one report rather than multiple reports. A check box, to indicate if a chemical substance is to be recycled, remanufactured, reprocessed, reused or reworked would be added.

Among other changes, EPA is proposing to revise and expand the list of industrial function categories and replace the NAICS codes with Industrial Sector Codes based on the European Union's "Guidance on information requirements and chemical safety assesment". The codes for consumer and commercial product categories would also be revised.

These lists of codes would be revised to bring them into harmony with existing codes used in Canada, to better facilitate the exchange of information between EPA and its Canadian counterpart and to serve as a model for Mexican agencies to develop an inventory of chemical substances.

Manufacturers and importers would be required to report the "total number of commercial workers likely to be exposed while using the reportable chemical substance(s):

iii. Number of commercial workers reasonably likely to be exposed.
EPA is proposing to require that submitters report the total number of
commercial workers, including those at sites not under the submitter's
control, that are reasonably likely to be exposed while using the
reportable chemical substance, with respect to each commercial use. The
approximate number of workers would be reported using the same
definitions and ranges used for manufacturing and industrial processing
and use workers required by 40 CFR 710.52(c)(3)(v) and (4)(i)(F)
(proposed 40 CFR 711.15(b)(3)(vii) and (4)(i)(F)), respectively. The
ranges are:

    Fewer than 10 workers.
    At least 10 but fewer than 25 workers.
    At least 25 but fewer than 50 workers.
    At least 50 but fewer than 100 workers.
    At least 100 but fewer than 500 workers.
    At least 500 but fewer than 1,000 workers.
    At least 1,000 but fewer than 10,000 workers.
    At least 10,000 workers.

    Information on the number of commercial workers reasonably likely
to be exposed to the reportable chemical substance would be used to
characterize the commercial population reasonably likely to be exposed
to the subject chemical substance. The population characterization is
important to the development of the overall exposure characterization.
 

Claims of "Confidential Business Information" - also known more commonly as "trade secrets" - would be required to be substantiated and claimed at the time the IUR is submitted and "should be limited only to those data elements the release of which would likely cause substantial harm to the business' competitive position. . . . EPA expects that reducing the number of CBI claims would increase the amount of information available to the public and improve the timeliness of its public availability". In a previous section, EPA noted that manufacturers would submit claims for CBI on information that was publicly available from other sources and thus was not CBI at all.

In Unit V of of the Supplemental Information, EPA requests comments on the proposed rule and various other topics, ranging from how best to use IUR data to take action on chemical substances that might pose "unreasonable risks" with particular emphasis on protecting children from exposure to harmful chemical substances to changing the reporting cycle, changes in how EPA should collect the information, and whether IUR reporting requirements should be changed to include processors as well as manufacturers and importers.

Comments must be submitted by October 12, 2010. The notice describes how comments need to be submitted. After receiving and reviewing the comments submitted, EPA hopes to publish a final rule in Spring 2011. As with any proposed rule submitted for public comment by any Federal agency, there may be a "Notice of Further Proposed Rulemaking" (NPRM) or the agency may also issue an interim rule before the final rule is published.

EPA has established a docket (EPA-HQ-OPPT-2009-0187) on www.regulations.gov  where documents referenced in the Supplemental Information and comments on the proposed rule may be found.

A shorter discussion of the proposed rule may also be found on the OMB Watch website.

New Edition of NanoLawReport

Here is the Summer 2010 edition of NanoLawReport.  Heading out to the beach for a few days to top off the summer.  :)

Massachusetts Issues Nano-EHS Guidance Document

This article originally appeared on the National Nanomanufacturing Network's InterNano website on August 25, 2010.  It is licensed under Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported.

Massachusetts’ Office of Technical Assistance and Technology (OTA) recently released its “OTA Technology Guidance Document: Nanotechnology - Considerations for Safe Development” which has been in development for the past couple of years. The document begins by noting the tremendous positive influence nanotechnology is predicted to have in the fields of biomedical devices, electronics, clean energy, and materials engineering, while at the same time acknowledging that “there are indications of potential harm from certain exposures and release of engineered nanoparticles.” OTA also believes that there “is little uncertainty” regarding available means to prevent potential workplace exposure to nanoscale materials. Simply put, despite unknown EHS risks, there is more than adequate knowledge to control potential exposure in OTA’s view.

The end of the report contains a bibliography of existing resources covering state-of-the-art workplace good practices for nanoscale materials. The bibliography includes the “usual suspect” documents and websites published by NIOSH, ICON, German government, British Standards Institute, ED/DuPont, NanoSafe, and ASTM. From these primary sources, OTA distills a basic set of good practices for entities working with nanoscale materials in Massachusetts.

First, establish a risk reduction plan for facilities working with nanoscale materials. Such a plan should have two levels. First, it should attempt to protect against direct and immediate worker exposure. Second, it should also attempt to protect against possible releases during transport, use, and disposal after the nanoscale materials leave the manufacturing facility.

Second, evaluate potential worker exposure to nanoscale materials during the manufacturing process and then implement a hierarchy of exposure controls, including: substituting source materials with non-nano substances where appropriate, implementing engineering controls, using administrative controls, and requiring the use of personal protective equipment. This is all standard NIOSH-fare drawn from NIOSH’s excellent “Approaches to Safe Nanotechnology: Managing the Risks and Safety Concerns Associated with Engineered Nanoparticles.” OTA’s guidance document, however, does a good job of drawing out the most important “nuggets” of information from the NIOSH document in a few short pages.

Third, analyze whether unintentional release of nanoscale materials may occur with consumer use or disposal of the product. Along these lines, OTA recommends companies consider: labeling products as already suggested by BSI and the EU, warning potentially affected downstream users and others regarding potential EHS risks through the use of the Material Safety Data Sheets and other written warnings, complying with existing environmental laws such as the Toxic Substances Control Act, conducting an open and transparent risk and hazard testing regime for the product throughout its complete lifecycle, and recognizing that proactive prevention of EHS concerns is required for successful commercialization of nanotechnology.

In the end, OTA’s document is a helpful quick reference guide, but it does not cover any new ground or delve deeply into its existing source material. Businesses involved in nanomanufacturing should still consult the underlying source material cited in the document, as well as EHS and legal experts as necessary. Massachusetts should be commended, however, for putting out this basic guidance document and attempting to proactively address these issues.
 

FDA Public Workshop on Medical Devices & Nanotechnology

Monday's federal register carried a notice from the Food & Drug Administration (FDA) announcing a public workshop on "Medical Devices & Nanotechnology: Manufacturing, Characterization, and Biocompatibility Considerations" to be held September 23 2010, from 8AM to 5PM at the Hilton Washington DC/North Gaithersburg, in Gathersburg, MD. Persons interested in participating in the workshop need to register by September 15, 2010. The notice provides a link and details on how to register. If anyone wishes to make an oral presentation during the workshop sessions, that needs to be indicated at the time of registration.

According to the notice

The objective of this public workshop is to obtain information on
manufacturing, characterization, and evaluation of biocompatibility of
medical devices containing or utilizing nanomaterials and
nanostructures.

Issues for Discussion

    The workshop will focus on two topics: (1) Manufacturing and
characterization of medical devices containing or utilizing
nanomaterials or nanostructures; (2) biocompatibility evaluation of
medical devices containing or utilizing nanomaterials or
nanostructures. The discussion on manufacturing and characterization
will include the evaluation of physico-chemical properties of
nanomaterials or nanostructures, characterization methods required,
device manufacturing processes and evaluation of the final processed
device after sterilization, and stability and aging studies. The
discussion on biocompatibility evaluation will include testing for
potential release of nanomaterials and additional testing
considerations other than standard testing methods to determine the
biocompatibility and toxicity of devices containing or utilizing
nanomaterials or structures.

Registrants for the workshop will be participate in the oral presentations discussed above and via two roundtable discussions between the FDA's staff and "selected participants representing a range of constituencies."

For more information, the notice does provide a contact person:

Contact Person: Daya Ranamukhaarachchi, Food and Drug
Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5574, Silver
Spring, MD 20993, 301-796-6155, FAX: 301-847-8510, email:
Daya.Ranamukhaarachchi@fda.hhs.gov.
 

Considering that the workshop begins at 8AM hopefully there will be plenty of coffee.

EPA Releases Draft Nanomaterial Case Study: Nanoscale Silver in Disinfectant Spray

The EPA recently released a draft of its "Nanomaterial Case Study: Nanoscale Silver in Disinfectant Spray" which you can download here.  The document is 323 pages long and has 6 chapters: (i) Introduction; (ii) Introduction to Silver and Nanoscale Silver; (iii) Life-Cycle Stages; (iv) Fate and Transport in Environmental Media; (v) Exposure, Uptake, and Dose; and (vi) Characterization of Effects.

In two chapters most pertinent to our readers, the document discusses the possible EHS ramifications of the manufacturing and use of nanoscale silver disinfectants over a wide-range of issues.  Regarding Life-Cycle Stages, the document covers five primary product stages: feedstocks; manufacturing; distribution and storage; use; and disposal.  Similarly, regarding fate and transport in the environment, the document discusses air, terrestrial, and aquatic systems and factors that effect transport and fate in each media.

Overall , the document appears to mirror the approach used in EPA's prior draft case study on nanoscale titanium dioxide used in drinking water systems and in sunscreens which was published in 2009. 

Written comments on the draft are due to EPA by September 27, 2010.

 

Nanotechnology A Policy Primer

The Congressional Research Service, in March of this year, released a report, "Nanotechnology: A Policy Primer", written by John F. Sargent, Jr., a specialist in Science and Technology Policy. The primer's first section focuses on a review of the National Nanotechnology Initiative (NNI). A table showing funding from various government agencies and departments for NNI shows that from FY 2006 to FR 2010, the Department of Defense (DOD) has been the largest single source of funding. However, this is about to change. In FY 2011, DOD will fall to 4th place, preceded by the Department of Energy (DOE), the National Science Foundation (NSF), and the Department of Health and Human Services (DHHS). This shifting of the majority of funding from DOD  may reflect a normal path of evolution; DOD has long been a source of funding for new technologies that eventually develop non-military uses. It may also reflect that future DOD budgets will not be as robust as they have been in the last few years.

Noting that "In the longer term, nanotechnology may deliver revolutionary advances with profound economic and societal implications", Part 2 of the CRS report considers briefly area that may be most affected by nanotech:

Detection and treatment technologies for cancer

"Clean, inexpensive, renewable power through energy creation, storage and transmission technologies"

Universal Access to clean water supplies, both in the US and less developed nations:  " Nanotechnology water desalination and filtration systems may offer affordable, scalable and portable water filtration systems".

"High density memory devices", improving the performance of computers and other devices.

Improved, more abundant crop yields and nutrition: " Higher crop yields might be achieved using nanoscale sensors that detect the presence of a virus or disease infecting particle . . . . Nanotechnology also offers the potential for improved nutrition. Some companies are exploring the development of nanocapsules that release nutrients targeted at specific parts of the body at specific times".

Self-healing materials

"Sensors that can warn of minute levels of toxic and pathogens in air, soil, or water."

Remediation of contaminated sites: ". . .  nanoscale particles . . . may offer more effective and less costly solution to environmental contamination."

The report also discusses other selected issues, primarily US competitiveness with other nations in the  nanotech area, using public and private investment, scientific papers published and cited, and patents issued as measurement parameters. The report notes that while the United States still leads all other nations in these areas, that lead has diminished over the last few years, with Japan, Germany and the People's Republic of China (PRC) poised to assume the lead. In these areas, the potential loss of US competitiveness is reflected in the debates in the media and Congress over free trade agreements (FTAs) and government policy towards the manufacturing sector and how best to aid it.

The report concludes with brief considerations of (1) environmental, health and safety implications of nanotechnology, (2) nanomanufacturing, and (3) public attitudes toward and understanding or misunderstanding of nanotech issues, noting that public support for nanotech tends to be greatest among those with advanced degrees and higher incomes.

 

EPA nanomaterial disclosure policy submitted to OMB for review

Inside Washington's Inside the EPA newsletter carries an article regarding the EPA's Office of Chemical Safety and Pollution Prevention submitting for review a notice outlining EPA's intention to use its existing regulatory authority under the Federal Insecticide, Fungicide & Rodenticide Act (FIFRA) to require that manufacturers of pesticides provide more information to EPA about their use of nanoscale materials in their products.

This proposed notice was discussed at a presentation by William Jordan of EPA's Office of Pesticide Programs (OPP) to the Pesticide Programs Dialogue Committee and also in a recent GAO report . The notice will also include OPP's definition of nanomaterials as ingredients containing particles between 1 and 100 nanometers in size.

During his presentation, Mr. Jordan noted that this new policy resulted from concerns expressed by the public about the potential toxic effects of nanoscale materials on the environment and humans. Industry groups and pesticide manufacturers also expressed their concern that the proposed rule could taint all nanomaterials as "adverse" and affect potential future sales of pesticides that include nanomaterials.

The text of the notice is not available from OMB's Reginfo.gov site. When it does appear in the Federal Register following OMB's review, it will be discussed and reviewed here.

UK budget cuts may lead to closing of nanotech centres

The UK's nanotech centres, receipients of GBP 50 million (roughly about 79.5 million dollars) under the previous Labour Party government, may become victims of the Conservative - Liberal Democrat coalition government's plans to reduce the UK budget deficit.

Appearing before the House of Commons Science and Technology Committee on July 23, 2010, Minister of State for Universities and Science David Willetts stated that the UK's nanotech research centres were "most unlikely" to be open in 18 months. Britian's Science Department, as with all Cabinet Departments, is facing budget cuts of between 25% - 40%. Under the Coalition government, Britain's regional development agencies (RDAs), under which the nanotech and other research centres fall, would be abolished and replaced by "Local Enterprise Partnerships" (LEPs)  These LEPs would be fewer and more centralized. The RDAs have been criticized for being "redundant and too expensive".

During his appearance before the Science and Technology Committee Mr. Willetts described the not yet established LEPs as "an effective device for supporting economic growth which includes initiative industries in the regions and local communities". He also suggested the Department for Business, Innovation and Skills would look into potential tax incentives for British industies to support science research.

The UK government is expected to publish a comprehensive budget review in October.

EPA Reopens Comment Period for Proposed SNUR for MWCNT

In a notice published in the Federal register on July 28, 2010, the Environmental Protection Agency (EPA) announced that it was adding new information to its public docket EPA-HQ-OPPT-2009-0686 and was reopening the comment period for  a proposed Significant New Use Rule (SNUR) for multiwalled carbon nanotubes (MWCNTS) first published in the Federal Register on February 3, 2010.

The proposed rule requires "persons who intend to manufacture, import, or process the substance" - described elsewhere in the notice as "multi-walled carbon nanotubes(generic)" to "be used as an additive/filler for polymer composites and support media for industrial catalysts" - "for an activity that is designated as a significant new use by this proposed rule to notify EPA at least 90 days before commencing that activity". This would give EPA time to assess "risks that may be presented by the intended uses and, if appropriate, to regulate the proposed use before it occurs."

Information regarding submission of comments will be found in the original notice of February 3, 2010.

The "Significant New Use" for the MWCNTS (generic) are described in the Feb. 3, 2010 notice as

certain changes from the use scenario described in the
PMN could result in increased exposures, thereby constituting a
``significant new use.'' EPA has determined that activities proposed as
a ``significant new use'' satisfy the two requirements stipulated in
Sec.  721.170(c)(2), i.e., these significant new use activities, ``(i)
are different from those described in the premanufacture notice for the
substance, including any amendments, deletions, and additions of
activities to the premanufacture notice, and (ii) may be accompanied by
changes in exposure or release levels that are significant in relation
to the health or environmental concerns identified'' for the PMN
substance.
 

EPA has determined, however, that use of the substance without the use of gloves and protective clothing, where there is a potential for dermal exposure;
use of the substance without a National Institute for Occupational
Safety and Health (NIOSH)-approved full-face respirator with an N100
cartridge, where there is a potential for inhalation exposure; or use
other than as described in the PMN, may cause serious health effects.
Based on this information, the PMN substance meets the concern criteria
at Sec.  721.170(b)(3)(ii).
 

Following the closing of the comment period and review of the comments received, EPA will publish summaries and EPA's replied to the submitted comments in a future issue of the Federal register, along with the final rule.

National Nanotechnology Innovation Summit

 

A National Nanotechnology Innovation Summit to mark the 10th anniversary of the National Nanotechnology Initiative (NNI) will be held December 8-10, 2010 at the Gaylord National Hotel & Convention Center in National Harbor, MD. The Nano Science and Technology Institute (NTSI) will join with the White House Office of Science & Technology (OSTP), the Nanotechnology Coordination Office (NNCO) and the National Venture Capital Association (NCVA) to organize the event. Launched in 2001, the NNI is a federal program which serves as the coordinating body for 25 federal agencies which conduct nanotechnology research and development. The Summit will be a forum for the nation’s top nanotechnology researchers, investors, policy makers, and developers to join in recognition of the NNI’s efforts in the field over the past ten years. More information and registration details are available at: http://www.nsti.org/events/NNI